Lilly ICOS LLC is the sponsor of all studies listed here.
 |
Drug Name: | Generic Name: | Title of Study: | Dates of Trial: |
| 1. | Cialis | tadalafil | A Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate The Efficacy And Safety of IC351 (5 mg And 10 mg) Administered Once Daily To Men With Erectile Dysfunction Reference Citations (PDF - 28k) |
September 17, 2001 - October 16, 2003 |
| 2. | Cialis | tadalafil | A Randomized, Double-Blind, Parallel, Placebo-Controlled Study To Evaluate The Efficacy And Safety of IC351 Administered “On Demand” To Men With Erectile Dysfunction Reference Citations (PDF - 28k) |
February 12, 2002 - December 6, 2002 |
| 3. | Cialis | tadalafil | Multinational Evaluation of the Efficacy, Safety and Treatment Satisfaction of Tadalafil administered “On Demand” to Men with Erectile Dysfunction Reference Citations (PDF - 32k) |
August 14, 2002 - July 21, 2003 |
| 4. | Cialis | tadalafil | A Randomized, Double-Blind, Parallel, Placebo-Controlled Study To Evaluate The Efficacy And Safety of IC351 Administered “On Demand” To Men With Erectile Dysfunction Reference Citations (PDF - 28k) |
October 7, 2002 - May 6, 2003 |
| 5. | Cialis | tadalafil | A Randomized, Double-blind, Parallel, Placebo-Controlled Study To Evaluate the Efficacy And Safety of IC351 (Tadalafil) Administered “On Demand” to Men with Erectile Dysfunction Reference Citations (PDF - 20k) |
October 21, 2002 - July 23, 2003 |
| 6. | Cialis | tadalafil | A Multicenter Open-Label Study to Determine Treatment Preference of Tadalfil (IC351, LY450190) or Sildenafil Citrate in the Oral Treatment of Erectile Dysfunction Reference Citations (PDF - 20k) |
October 31, 2003 - November 22, 2004 |
| 7. | Cialis | tadalafil | A Randomized, Crossover, Open-Label Study of IC351 (LY450190) Administered to Patients with Erectile Dysfunction Assessing Patient Preference for Either an "On-Demand" or a "Scheduled" Treatment Regimen Reference Citations (PDF - 40k) |
October 14, 2002 - July 2, 2003 |
| 8. | Cialis | tadalafil | A Multicenter, Randomized, Double-Blind, Parallel, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tadalfil Administered "On-Demand" to Asian Men with Erectile Dysfunction Reference Citations (PDF - 44k) |
May 8, 2003 - December 23, 2003 |
| 9. | Cialis | tadalafil | An Open-Label Study to Evaluate the Efficacy and Safety of Tadalfil Administered "On Demand" to Men of Various Populations with Erectile Dysfunction Reference Citations (PDF - 40k) |
August 22, 2003 - March 12, 2004 |
Cialis has been approved for marketing in the United States and many other countries worldwide for treatment of erectile dysfunction. This information is posted pursuant to the requirements of 22 Maine Revised Statutes § 2700-A; it is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved use of Lilly ICOS products. Prescribing decisions should be made based on the applicable approved package insert. Prescribing information approved in the United States is available at www.fda.gov; healthcare professionals in other countries should consult the prescribing information approved in their country.
Nothing on this website should be construed as giving advice or making a recommendation. This information is not intended to replace the advice of a health care professional; only a physician can determine if a specific treatment is suitable for a particular patient.